Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Brown

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Urology|March 23, 2022
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate CancerBenjamin Lowentritt, Gordon Brown, Dominic Pilon, et al.
Urologic Oncology|March 28, 2025
Corrigendum to 'Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide'[Urol Oncol: Semin Original Investigat 41(3) (2023) 253.e1-253.e9]Benjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, et al.
Electrochimica Acta|March 18, 2014
The Impact of Enzyme Orientation and Electrode Topology on the Catalytic Activity of Adsorbed Redox EnzymesDuncan G G McMillan, Sophie J Marritt, Gemma L Kemp, et al.
Journal of Environmental Monitoring : JEM|April 17, 2010
Field turbidity method for the determination of lead in acid extracts of dried paintWilliam B Studabaker, Michelle McCombs, Kristen Sorrell, et al.
British Journal of Haematology|October 25, 2013
hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemiaAnne S Roug, Hanne Ø Larsen, Line Nederby, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 2, 2026
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United StatesNeal Shore, Benjamin Lowentritt, Charmi Patel, et al.
Urologic Oncology|April 15, 2023
Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamideBenjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, et al.
Journal of the American Dental Association (1939)|October 2, 2012
Advancing infection control in dental care settings: factors associated with dentists' implementation of guidelines from the Centers for Disease Control and PreventionJennifer L Cleveland, Arthur J Bonito, Tammy J Corley, et al.
Journal of Rehabilitation Research and Development|June 7, 2007
Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain?Jillian C Shipherd, Megan Keyes, Tanja Jovanovic, et al.
Targeted Oncology|December 6, 2022
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for MetastasesGordon Brown, Laurence Belkoff, Jason M Hafron, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Urology|March 23, 2022
Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients With Non-Metastatic Castration-Resistant Prostate CancerBenjamin Lowentritt, Gordon Brown, Dominic Pilon, et al.
Urologic Oncology|March 28, 2025
Corrigendum to 'Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamide'[Urol Oncol: Semin Original Investigat 41(3) (2023) 253.e1-253.e9]Benjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, et al.
Electrochimica Acta|March 18, 2014
The Impact of Enzyme Orientation and Electrode Topology on the Catalytic Activity of Adsorbed Redox EnzymesDuncan G G McMillan, Sophie J Marritt, Gemma L Kemp, et al.
Journal of Environmental Monitoring : JEM|April 17, 2010
Field turbidity method for the determination of lead in acid extracts of dried paintWilliam B Studabaker, Michelle McCombs, Kristen Sorrell, et al.
British Journal of Haematology|October 25, 2013
hMICL and CD123 in combination with a CD45/CD34/CD117 backbone - a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemiaAnne S Roug, Hanne Ø Larsen, Line Nederby, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 2, 2026
Real-World Clinical and Economic Outcomes Among Patients with Localized Prostate Cancer Undergoing Radical Prostatectomy Across Different Risk Stratifications in the United StatesNeal Shore, Benjamin Lowentritt, Charmi Patel, et al.
Urologic Oncology|April 15, 2023
Attainment of early, deep prostate-specific antigen response in metastatic castration-sensitive prostate cancer: A comparison of patients initiated on apalutamide or enzalutamideBenjamin Lowentritt, Dominic Pilon, Ibrahim Khilfeh, et al.
Journal of the American Dental Association (1939)|October 2, 2012
Advancing infection control in dental care settings: factors associated with dentists' implementation of guidelines from the Centers for Disease Control and PreventionJennifer L Cleveland, Arthur J Bonito, Tammy J Corley, et al.
Journal of Rehabilitation Research and Development|June 7, 2007
Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain?Jillian C Shipherd, Megan Keyes, Tanja Jovanovic, et al.
Targeted Oncology|December 6, 2022
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for MetastasesGordon Brown, Laurence Belkoff, Jason M Hafron, et al.
Pageof 9